Table 1.

GEO studies used to validate DeSigN prediction

GEO reference	Drug	Response	Number of sensitive samples	Number of resistant samples	Platform	Reference
GSE4342	Gefitinib	Sensitive	17	12	GPL96	Coldren et al. [24]
GSE16179	Lapatinib	Sensitive	3	3	GPL570	Liu et al. [35]
GSE9633	Dasatinib	Sensitive	11	5	GPL571	Wang et al. [36]
GSE35141	Gemcitabine	Resistant	6	6	GPL4133	Saiki et al. [37]